Tower Research Capital (TRC)’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.29K | Sell |
479
-440
| -48% | -$5.78K | ﹤0.01% | 4115 |
|
|
2025
Q1 | $13.2K | Sell |
919
-942
| -51% | -$13.5K | ﹤0.01% | 3390 |
|
|
2024
Q4 | $31.2K | Sell |
1,861
-428
| -19% | -$7.17K | ﹤0.01% | 2880 |
|
|
2024
Q3 | $36.6K | Buy |
2,289
+991
| +76% | +$15.8K | ﹤0.01% | 2898 |
|
|
2024
Q2 | $11.7K | Buy |
1,298
+288
| +29% | +$2.6K | ﹤0.01% | 4067 |
|
|
2024
Q1 | $11.4K | Sell |
1,010
-1,293
| -56% | -$14.6K | ﹤0.01% | 3570 |
|
|
2023
Q4 | $18.3K | Sell |
2,303
-763
| -25% | -$6.07K | ﹤0.01% | 3705 |
|
|
2023
Q3 | $19.8K | Sell |
3,066
-1,206
| -28% | -$7.8K | ﹤0.01% | 3381 |
|
|
2023
Q2 | $26.4K | Sell |
4,272
-4,302
| -50% | -$26.6K | ﹤0.01% | 3116 |
|
|
2023
Q1 | $33K | Sell |
8,574
-7,597
| -47% | -$29.2K | ﹤0.01% | 2886 |
|
|
2022
Q4 | $51K | Buy |
16,171
+10,894
| +206% | +$34.4K | ﹤0.01% | 2327 |
|
|
2022
Q3 | $21K | Buy |
5,277
+3,800
| +257% | +$15.1K | ﹤0.01% | 3888 |
|
|
2022
Q2 | $7K | Buy |
1,477
+232
| +19% | +$1.1K | ﹤0.01% | 4774 |
|
|
2022
Q1 | $11K | Buy |
1,245
+315
| +34% | +$2.78K | ﹤0.01% | 4155 |
|
|
2021
Q4 | $10K | Buy |
930
+811
| +682% | +$8.72K | ﹤0.01% | 4540 |
|
|
2021
Q3 | $2K | Sell |
119
-958
| -89% | -$16.1K | ﹤0.01% | 5242 |
|
|
2021
Q2 | $24K | Buy |
+1,077
| New | +$24K | ﹤0.01% | 3717 |
|